Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Trazodone Prolonged-Release in Healthy Chinese Volunteers
NCT02785614Phase 1Completed
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- May 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of trazodone hydrochloride prolonged-release tablets in major depressive disorder (MDD) (2 arms), sponsored by Lee's Pharmaceutical Holdings Limited. Primary endpoint: Area Under Curve at Day 7. Started May 2017; status: completed.
02
Drugs
trazodone hydrochloride prolonged-release tablets
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02785614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02785614.